OQS
IRD

Occudo Quantitative Strategies’s Opus Genetics IRD Stock Holding History

Occudo Quantitative Strategies’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,205
Closed -$24.5K – 967
2025
Q4 		$24.5K Buy
+12,205
New +$24.8K ﹤0.01% 670
2023
Q2 		– Sell
-19,623
Closed -$73.6K – 1337
2023
Q1 		$73.6K Buy
+19,623
New +$70.5K 0.01% 836
2022
Q2 		– Sell
-18,600
Closed -$60K – 1432
2022
Q1 		$60K Buy
18,600
+150
+0.8% +$513 0.01% 1063
2021
Q4 		$69K Sell
18,450
-3,269
-15% -$13.1K 0.01% 993
2021
Q3 		$112K Sell
21,719
-1,726
-7% -$7.96K 0.01% 916
2021
Q2 		$124K Buy
+23,445
New +$116K 0.02% 777

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Occudo Quantitative Strategies's IRD Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Opus Genetics (IRD) in Q1 2026, closing a stake of 12,205 shares — an estimated $24.5K sold.

Occudo Quantitative Strategies first reported a position in IRD in Q2 2021 and held it in 6 quarters. The position peaked at $124K in Q2 2021. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Opus Genetics position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 12,205 Opus Genetics shares in Q1 2026, an estimated $24.5K.
  • Occudo Quantitative Strategies first reported a position in Opus Genetics in Q2 2021 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Opus Genetics position peaked at $124K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.